Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZYNERGY: Petrelintide + Enicepatide in Obesity or Overweight
NCT07589686Phase 2Not yet recruiting
- Sponsor
- Roche
- Start
- Sep 2026
- Primary completion
- Nov 2027
- Modality
- Hormonal Peptides
01
Overview
A Phase 2 trial of petrelintide, zilebesiran in obesity, sponsored by Roche. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
petrelintidezilebesiran
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07589686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07589686.